BioMarin Pharmaceutical Acquires Inozyme
BioMarin Pharmaceutical acquired Inozyme for $270.0M. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- BioMarin Pharmaceutical
- Acquired Company
- Inozyme
- Price
- $270.0M
- Acquisition Type
- Merger
- Announced
- May 16, 2025
Canonical: https://fsome.com/acquisitions/biomarin-pharmaceutical-acquires-inozyme-8050549 · For the full deal terms, timeline, and press references, please enable JavaScript.